Dryvax

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Smallpox

Phase 1

Human Immune Responses Smallpox

CompletedNCT00068198

National Institute of Allergy and Infectious Diseases (NIAID)Smallpox

End: 2004-11-30Target: 45Updated: 2010-08-27

Phase 2

Dryvax Dilution-Prev Vacc Adults

CompletedNCT00032708

National Institute of Allergy and Infectious Diseases (NIAID)Smallpox

Start: 2004-04-30End: 2004-11-30Target: 90Updated: 2010-08-27